½ÃÀ庸°í¼­
»óǰÄÚµå
1540833

¼¼°èÀÇ ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå º¸°í¼­ : ½Ã¼ú À¯Çü, Àåºñ À¯Çü, ½Ã¼ú, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº°(2024-2032³â)

Bariatric Surgery Devices Market Report by Procedure Type, Device Type, Procedure, Application, End-User, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 142 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 29¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC ±×·ìÀº 2032³â±îÁö ½ÃÀå ±Ô¸ð°¡ 44¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2024-2032³â°£ 4.6%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù.

ºñ¸¸ ¼ö¼ú ±â±â´Â ºñ¸¸ ¼ö¼úÀ» ¼öÇàÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÓ»ó Àåºñ¸¦ ¸»ÇÕ´Ï´Ù. ÀÌ ½Ã¼úÀº À§°¡ º¸À¯ÇÒ ¼ö ÀÖ´Â À½½ÄÀÇ ¾çÀ» Á¦ÇÑÇÏ°í ¿µ¾ç¼ÒÀÇ Èí¼ö Àå¾Ö¸¦ ÀÏÀ¸ÄÑ Ã¼Áß °¨¼Ò¸¦ µ½½À´Ï´Ù. ¶ÇÇÑ ½Ä¿åÀ» °¨¼Ò½ÃŰ°í Æ÷¸¸°¨À» À¯¹ßÇÏ´Â Àå³» È£¸£¸óÀÇ »ý»êÀ» Áõ°¡½ÃŰ´Â µ¥ µµ¿òÀ» ÁÝ´Ï´Ù. ÀÌ·± À¯ÇüÀÇ ¼ö¼ú¿¡ »ç¿ëµÇ´Â ÀϹÝÀûÀÎ º¸Á¶±â±¸ ¹× À̽ÄÇü±â±¸¿¡´Â ½ºÅ×ÀÌÇøµ±â±¸, Ç÷°ü ºÀ¼â±â±¸, ºÀÇձⱸ, Æ®·ÎÄ¿, Á¶Á¤ °¡´ÉÇÑ À§¹êµå, À§ dz¼±, Àü±â Àڱرⱸ µîÀÌ ÀÖ½À´Ï´Ù.

ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå µ¿Çâ :

ºñ¸¸, ´ç´¢º´, ½ÉÇ÷°ü Áúȯ(CVDs)°ú °°Àº ´Ù¾çÇÑ »ýȰ½À°üº´ÀÇ À¯º´·ü Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. Àü ¼¼°è Àα¸ÀÇ ´ë´Ù¼ö°¡ ¾É¾Æ¼­ »ýȰÇÏ´Â ½À°ü°ú °Ç°­¿¡ ÇØ·Î¿î ½Ä½À°üÀ¸·Î ÀÎÇØ üÁß°ú °ü·ÃµÈ ¹®Á¦ÀÇ »ç·Ê°¡ Å©°Ô Áõ°¡ÇÏ¿© ºñ¸¸ ¼ö¼úÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Å« Àý°³°¡ ÇÊ¿ä ¾ø°í ¼ö¼ú ÈÄ ½ºÆ®·¹½º¸¦ ÃÖ¼ÒÈ­ÇÏ´Â ÃÖ¼Òħ½À(MI) ºñ¸¸ ¼ö¼ú ¹× Àåºñ¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀå¿¡ ÈûÀ» º¸Å°í ÀÖ½À´Ï´Ù. ¹Ì¿ë È¿°ú¸¦ ³ôÀ̰í ÅëÁõÀ» ÃÖ¼ÒÈ­ÇÏ´Â ±â±¸ÀÇ °³¹ß µî ´Ù¾çÇÑ ¹ßÀüµµ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ´õºÒ¾î POSE(Primary Obesity Surgery Endoluminal), LGCP(Laparoscopic Greater Curvature Plication), HALS(Hand-Assisted Laparoscopic Surgery) µî ¼ö¼ú ¹æ¹ýÀÇ °³¼±µµ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¼ö¼ú ¹æ¹ýÀÇ °³¼±µµ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ ¹Û¿¡µµ ´ëÁßÀÇ °Ç°­ ÀÇ½Ä Çâ»ó°ú ¼ö¼ú¿ë ·Îº¿ÀÇ µµÀÔ µîÀÌ ½ÃÀåÀ» ´õ¿í °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®µé

  • ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå ¼¼°è ½ÃÀå ±Ô¸ð´Â?
  • 2024-2032³â ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº?
  • Äڷγª19°¡ ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ½Ã¼ú À¯Çüº° ½ÃÀå ÇöȲÀº?
  • ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ Àåºñ À¯Çüº° ½ÃÀå ÇöȲÀº?
  • ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ½Ã¼úº° ½ÃÀå ±Ô¸ð´Â?
  • ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ¿ëµµº° ½ÃÀå ÇöȲÀº?
  • ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ÃÖÁ¾ »ç¿ëÀÚº° ºÐ¼®Àº?
  • ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°è ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀåÀÇ ÁÖ¿ä ÁøÃâ ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • º¸ÅÒ¾÷ Á¢±Ù
    • Åé´Ù¿î Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ºñ¸¸ ¼ö¼ú ±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ºÐ¼®
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ºÐ¼® : ½Ã¼ú À¯Çüº°

  • Àúħ½À¼ö¼ú
  • ºñħ½À¼ö¼ú

Á¦7Àå ½ÃÀå ºÐ¼® : ±â±â À¯Çüº°

  • º¸Á¶ ±â±â
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä À¯Çü
      • Gastric Bands
      • Electrical Stimulators
      • Gastric Balloons
      • Transpyloric Shuttle
      • ±âŸ
    • ½ÃÀå ¿¹Ãø
  • À̽ÄÇü ±â±â
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä À¯Çü
      • À§¹êµå
      • Àü±â ÀÚ±Ø ±â±â
      • À§³» dz¼±
      • Transpyloric Shuttle
      • ±âŸ
    • ½ÃÀå ¿¹Ãø

Á¦8Àå ½ÃÀå ºÐ¼® : ½Ã¼úº°

  • Sleeve Gastrectomy
  • Adjustable Gastric Banding
  • Roux-en-Y Gastric Bypass
  • Biliopancreatic Diversion with Duodenal Switch
  • ±âŸ

Á¦9Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °¨·®
  • À¯Àü¼º Áúȯ
  • ±âŸ Áúȯ

Á¦10Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • ºñ¸¸ ¿Ü°ú Ŭ¸®´Ð
  • º´¿ø
  • ±âŸ

Á¦11Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ºÐ¼® : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦12Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦13Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦14Àå PorterÀÇ Five Forces ºÐ¼®

  • °³¿ä
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦15Àå °¡°Ý ÁöÇ¥

Á¦16Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Apollo Endosurgery Inc.
    • GI Dynamics
    • Intuitive Surgical Inc.
    • Johnson & Johnson Services Inc.
    • Medtronic Inc.
    • Olympus Corporation
    • Reach Surgical Inc.
    • Reshape Lifesciences Inc.
    • Spatz Fgia Inc.
    • TransEnterix Inc.
    • USGI Medical Inc.
LSH 24.09.03

The global bariatric surgery devices market size reached US$ 2.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.

Bariatric surgery devices refer to the clinical equipment used for conducting bariatric procedures. These procedures aid in weight loss by restricting the amount of food that the stomach can hold and causing malabsorption of nutrients. They also aid in enhancing the production of gut hormones that reduce appetite and provide the feeling of satiety. Some of the common assisting and implantable devices used during this type of surgery include stapling devices, vessel sealing devices, suturing devices, trocars, adjustable gastric bands, gastric balloons, electrical stimulators, etc.

Bariatric Surgery Devices Market Trends:

The increasing prevalence of various lifestyle disorders, such as obesity, diabetes and cardiovascular diseases (CVDs), is one of the key factors driving the growth of the market. Owing to the sedentary lifestyle habits and unhealthy dietary patterns of the majority of the population across the globe, there has been a significant increase in the instances of weight-related problems, which is escalating the need for bariatric surgeries. Furthermore, the growing preference for minimally invasive (MI) bariatric procedures and devices that eliminate the need for large incisions and cause minimal postoperative stress have also provided a boost to the market growth. Various advancements, such as the development of devices with improved cosmetic results and minimal pain, is acting as another growth-inducing factor. In addition to this, improvements in the surgical procedures, such as Primary Obesity Surgery Endoluminal (POSE), Laparoscopic Greater Curvature Plication (LGCP) and Hand-Assisted Laparoscopic Surgery (HALS), are also creating a positive impact on the market. Other factors, including the increasing health consciousness among the masses, along with the adoption of surgical robots, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bariatric surgery devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on procedure type, device type, procedure, application and end-user.

Breakup by Procedure Type:

Minimally Invasive Surgical Procedures

Non-Invasive Surgical Procedures

Breakup by Device Type:

Assisting Devices

Stapling Devices

Energy Based Vessel Sealing Devices

Suturing Devices

Trocars

Clip Appliers

Others

Implantable Devices

Gastric Bands

Electrical Stimulators

Gastric Balloons

Transpyloric Shuttle

Others

Breakup by Procedure:

Sleeve Gastrectomy

Adjustable Gastric Banding

Roux-en-Y Gastric Bypass

Biliopancreatic Diversion with Duodenal Switch

Others

Breakup by Application:

Weight Loss

Hereditary Disease

Other Disorders

Breakup by End-User:

Bariatric Surgery Clinics

Hospitals

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Apollo Endosurgery Inc., GI Dynamics, Intuitive Surgical Inc., Johnson & Johnson Services Inc., Medtronic Inc., Olympus Corporation, Reach Surgical Inc., Reshape Lifesciences Inc., Spatz Fgia Inc., TransEnterix Inc., USGI Medical Inc., etc.

Key Questions Answered in This Report

  • 1. How big is the global bariatric surgery devices market?
  • 2. What is the expected growth rate of the global bariatric surgery devices market during 2024-2032?
  • 3. What are the key factors driving the global bariatric surgery devices market?
  • 4. What has been the impact of COVID-19 on the global bariatric surgery devices market?
  • 5. What is the breakup of the global bariatric surgery devices market based on the procedure type?
  • 6. What is the breakup of the global bariatric surgery devices market based on the device type?
  • 7. What is the breakup of the global bariatric surgery devices market based on the procedure?
  • 8. What is the breakup of the global bariatric surgery devices market based on the application?
  • 9. What is the breakup of the global bariatric surgery devices market based on the end user?
  • 10. What are the key regions in the global bariatric surgery devices market?
  • 11. Who are the key players/companies in the global bariatric surgery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bariatric Surgery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Procedure Type

  • 6.1 Minimally Invasive Surgical Procedures
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Invasive Surgical Procedures
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Device Type

  • 7.1 Assisting Devices
    • 7.1.1 Market Trends
    • 7.1.2 Major Types
      • 7.1.2.1 Stapling Devices
      • 7.1.2.2 Energy Based Vessel Sealing Devices
      • 7.1.2.3 Suturing Devices
      • 7.1.2.4 Trocars
      • 7.1.2.5 Clip Appliers
      • 7.1.2.6 Others
    • 7.1.3 Market Forecast
  • 7.2 Implantable Devices
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Gastric Bands
      • 7.2.2.2 Electrical Stimulators
      • 7.2.2.3 Gastric Balloons
      • 7.2.2.4 Transpyloric Shuttle
      • 7.2.2.5 Others
    • 7.2.3 Market Forecast

8 Market Breakup by Procedure

  • 8.1 Sleeve Gastrectomy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Adjustable Gastric Banding
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Roux-en-Y Gastric Bypass
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Biliopancreatic Diversion with Duodenal Switch
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Weight Loss
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hereditary Disease
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Other Disorders
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Bariatric Surgery Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Apollo Endosurgery Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 GI Dynamics
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Intuitive Surgical Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Johnson & Johnson Services Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Medtronic Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Olympus Corporation
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Reach Surgical Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Reshape Lifesciences Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
    • 16.3.9 Spatz Fgia Inc.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 TransEnterix Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
    • 16.3.11 USGI Medical Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦